Invesco
VTYX

Invesco’s Ventyx Biosciences VTYX Stock Holding History

Invesco’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-49,468
Closed -$154K – 3877
2025
Q3 		$154K Sell
49,468
-33,174
-40% -$87.9K ﹤0.01% 3618
2025
Q2 		$177K Sell
82,642
-34,420
-29% -$55.6K ﹤0.01% 3545
2025
Q1 		$135K Sell
117,062
-28,562
-20% -$49K ﹤0.01% 3590
2024
Q4 		$319K Sell
145,624
-1,030
-0.7% -$2.33K ﹤0.01% 3398
2024
Q3 		$320K Sell
146,654
-406
-0.3% -$934 ﹤0.01% 3395
2024
Q2 		$340K Buy
147,060
+2,021
+1% +$8.4K ﹤0.01% 3446
2024
Q1 		$798K Buy
145,039
+120,781
+498% +$552K ﹤0.01% 3103
2023
Q4 		$59.9K Sell
24,258
-2,502
-9% -$23.8K ﹤0.01% 3737
2023
Q3 		$929K Buy
26,760
+602
+2% +$20.8K ﹤0.01% 2896
2023
Q2 		$858K Buy
26,158
+12,126
+86% +$418K ﹤0.01% 2968
2023
Q1 		$470K Buy
14,032
+5,378
+62% +$209K ﹤0.01% 3292
2022
Q4 		$284K Buy
8,654
+1,755
+25% +$52K ﹤0.01% 3531
2022
Q3 		$241K Buy
+6,899
New +$153K ﹤0.01% 3616

Other funds holding VTYX

AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco's VTYX Position: Q4 2025 in Review

Invesco sold out of Ventyx Biosciences (VTYX) in Q4 2025, closing a stake of 49,468 shares — an estimated $154K sold.

Invesco first reported a position in VTYX in Q3 2022 and held it in 13 quarters. The position peaked at $929K in Q3 2023. 139 funds tracked by Wall St. Rank hold VTYX as of Q4 2025.

  • Invesco reported no remaining Ventyx Biosciences position as of Q4 2025 after selling out during the quarter.
  • Invesco sold 49,468 Ventyx Biosciences shares in Q4 2025, an estimated $154K.
  • Invesco first reported a position in Ventyx Biosciences in Q3 2022 and held it in 13 quarters.
  • Invesco's Ventyx Biosciences position peaked at $929K in Q3 2023.
  • 139 funds tracked by Wall St. Rank held Ventyx Biosciences as of Q4 2025.

Based on Invesco's 13F filing for Q4 2025, filed 19 Feb 2026.